All filters
Abstracts
Concentration-QTcF modelling and drug-drug interaction of Bedaquiline, Pretomanid and Clofazimine in TB patients.
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Incidence and determinants of linezolid toxicity in patients with drug-resistant tuberculosis in a high HIV prevalence setting
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
A model-guided weight-banded dosing strategy for once daily delamanid in children
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
A model-based analysis of bedaquiline-related QTcF prolongation in the PROBeX study
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
A Population Pharmacokinetic Model of Linezolid enabling Model-Informed Precision Dosing in Resistant Tuberculosis Patients
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Cerebrospinal Fluid Concentrations of New and Repurposed Drugs among Patients with Tuberculosis Meningitis
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Evaluating the effect of clofazimine against Mycobacterium tuberculosis
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Exposure-response relationship for bedaquiline, delamanid, and their metabolites
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Investigating the treatment shorting potential of sutezolid-containing regimens in a murine model with confirmed drug exposures
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Operational Challenges with Centralising PK Bioanalysis in a Multicentre Multinational Randomised Controlled Trial
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Optimized loading period strategies for bedaquiline at the restart of drug-resistant tuberculosis treatment
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Pentamidine shows promising activity against M. tuberculosis and M. avium complex but not M. abscessus
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Pharmacokinetics of linezolid in Indian patients with multidrug-resistant tuberculosis
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Pharmacokinetics of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
PLASMA BEDAQUILINE LEVELS IN INDIAN MDR-TB PATIENTS
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Population pharmacokinetics of cycloserine, administered as terizidone, in South African children treated for rifampicin-resistant tuberculosis.
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Population Pharmacokinetic Modeling of Pretomanid Dispersible-Tablet Formulation in Healthy Volunteers
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Pravastatin pharmacokinetics when administered simultaneously with first-line tuberculosis treatment
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Rifampin Urine Colorimetry for Evaluation of Tuberculosis Pharmacokinetics
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021
Abstracts
Simulation by oral dosing of rifapentine-rifabutin exposures for long-acting formulations in a mouse model of tuberculosis preventive therapy
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2021